Former Bangladesh PM Khaleda Zia sentenced to seven years in jail

Agencies

October 29, 2018

Dhaka, Oct 29: Former Bangladesh Prime Minister Khaleda Zia on Monday was sentenced to seven years in jail in a case involving a charity fund named after her late husband.

Judge Md Akhtaruzaman of a special court in Dhaka found her guilty of misuse of power as Prime Minister in collecting $375,000 for the Zia Charitable Trust Fund from unknown sources.

Ms Zia was absent in court as she is in hospital while serving a prison term of five years in a separate case.

In February, another court sentenced Ms Zia to five years in jail in a charity corruption case.

The judge also sentenced three others to seven years in jail each for collecting the money from undeclared sources.

Ms Zia’s party says the charges in both the cases are politically motivated.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments